Following the success of the HealthTech Investment Forum in Basel, we are happy to announce the European HealthTech CEO Forum, which will take place on the 18th of February at Hilton Zurich Airport Hotel, just a day before our European Life Sciences CEO Forum. We anticipate over 200 delegates, covering innovation in the digital health and medtech and devices sectors, with the target audience being corporate and financial investors/partners and advisors. The programme will feature topical keynotes and panels with industry leaders and over 20 corporate presentations by public, private and growth companies, and 20+ pitches by seed companies. Networking is supported by the online One-2-One meeting system which allows for pre-arranged meetings at the dedicated meeting facilities.
Panel Discussions will Include:
Future Vision of HealthTech & Partnering with Strategics Panel
MedTech & Device Innovation Panel
Cloud Computing in HealthTech Panel
Rising Stars: Global Seed Session
Confirmed Keynote Speeches by:
“This Decades’ Medical Technology & Healthcare Innovation: Some Interesting & Innovative Market Segments” by Jeffrey Cohen, Managing Director, Equity Research, Ladenburg Thalmann & Co. Inc.
Confirmed Speakers & Chairs Include:
Anne-Kathrin Witt, Director Digital BD&L, Novartis International AG
Ashish Patel, Principal, Optum Ventures
Beat Merz, Managing Director, New Harbor Venture Partners, LLC
Damien Ng, Thematic Research Analyst - Next Generation, Bank Julius Baer & Co. Ltd.
Dan Gilbertson, Director, Business Development & Strategy EMEA, Medtronic
Danny Lustiger, Co-Founder & CEO, MedCu Technologies Ltd.
David Gordon, Head of Investments, Longliv Ventures, a member of CK Hutchison Holdings
Diana Saraceni, Co-Founder & General, Partner, Panakès Partners SGR SpA
Elena Bonfiglioli, Managing Director Health and Life Sciences, EMEA, Microsoft Corporation
Guy Spigelman, Healthcare & Life Sciences Business Development, Amazon Web Services (AWS)
Ivano Ortis, Managing Director, Boston Consulting Group
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Presenters at the EHTF Forum Include:
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at the European HealthTech CEO Forum is an effective way to gain leads, introduce new products and services, expand sales, and build relationships. Exhibition space is very limited - express your interest to secure the area.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
FINANCIAL, ADVISORY, INVESTORS ATTENDING:
aescuvest international GmbH Aglaia BioMedical Ventures ARTO AG ATGN Consulting Banca del Ceresio Banque Profil de Gestion SA Bellevue Asset Management AG Bergmann zur Hausen & Cie. GmbH BERNINA BioInvest Ltd BioMedPartners AG Bioqube Ventures BioScience Managers Pty Ltd. BioStart Consulting GmbH Boehringer Ingelheim Venture Fund GmbH BOHE Angel Fund Bootstrap Europe Boston Consulting Group Breslin AG BROTHERS & PARTNERS EUROPE Capital Grand Est Capricorn Partners NV Debiopharm Innovation Fund SA Delin Ventures Ltd. E.Gutzwiller & Cie, Banquiers Earlybird Venture Capital ErfindungsVerwertung AG (EVA) Ernst & Young AG European Investment Bank FastVentures B.V. Fraser Finance LLP FutuRx Ltd. Genextra S.p.A. GL Capital Group GLSV GmbH Goetzpartners Securities H.C. Wainwright & Co., LLC Hadean Ventures Heal Capital High-Tech Gründerfonds Management GmbH ICF Consult (Switz.) Indaco Venture Partners SGR SpA Industrifonden Inkef Capital B.V. Innogest Capital Inserm Transfert Initiative / Sofimac Inveready Asset Management IPF Partners Joint Polish Investment Fund Julius Baer Ltd. Kreos Capital Management (UK) Ltd. Ladenburg, Thalmann & Co., Inc. LBBW Venture Capital Life Science Investments & Solutions GmbH LifeCare Partners LifeSci Advisors Lombard Odier Longliv Ventures, a member of CK Hutchison Holdings MainFirst Bank AG Medtronic Mérieux Equity Partners Momentum Biotech